INSPECS Group plc (AIM: SPEC)
London
· Delayed Price · Currency is GBP · Price in GBX 42.00
0.00 (0.00%)
Jan 20, 2025, 5:07 PM GMT+1
INSPECS Group Revenue
INSPECS Group had revenue of 103.05M GBP in the half year ending June 30, 2024, a decrease of -1.68%. This brings the company's revenue in the last twelve months to 195.14M, down -5.89% year-over-year. In the year 2023, INSPECS Group had annual revenue of 203.29M with 1.16% growth.
Revenue (ttm)
195.14M
Revenue Growth
-5.89%
P/S Ratio
0.21
Revenue / Employee
116.64K
Employees
1,673
Market Cap
40.67M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |